Literature DB >> 17196465

Relative merits of M-mode echocardiography and tissue Doppler imaging for prediction of response to cardiac resynchronization therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

Gabe B Bleeker1, Martin J Schalij, Eric Boersma, Eduard R Holman, Paul Steendijk, Ernst E van der Wall, Jeroen J Bax.   

Abstract

M-mode echocardiography (using the septal-to-posterior wall motion delay [SPWMD]) and color-coded tissue Doppler imaging (TDI; using the septal-to-lateral delay in peak systolic velocity) have been proposed for assessment of left ventricular (LV) dyssynchrony and prediction of response to cardiac resynchronization therapy (CRT). In this study, a head-to-head comparison between M-mode echocardiography and color-coded TDI was performed for assessment of LV dyssynchrony and prediction of response to CRT. Consecutive (n = 98) patients with severe heart failure (New York Heart Association class III/IV), LV ejection fraction < or =35%, and QRS duration >120 ms underwent CRT. Before pacemaker implantation, LV dyssynchrony was assessed by M-mode echocardiography (SPWMD) and color-coded TDI (septal-to-lateral delay). At baseline and 6 months after implantation, clinical and echocardiographic parameters were evaluated. SPWMD measurement was not feasible in 41% of patients due to akinesia of the septal and/or posterior walls or poor acoustic windows. Conversely, the septal-to-lateral delay could be assessed in 96% of patients. At 6-month follow-up, 75 patients (77%) were classified as responders to CRT (improvement > or =1 New York Heart Association class). The sensitivity and specificity of SPWMD were lower compared with those of septal-to-lateral delay (66% vs 90%, p <0.05; 50% vs 82%, p = NS, respectively). In conclusion, LV dyssynchrony assessment was feasible in 59% of patients with M-mode echocardiography compared with 96% (p <0.05) when color-coded TDI was used. Color-coded TDI was superior to M-mode echocardiography for prediction of response to CRT.

Entities:  

Mesh:

Year:  2006        PMID: 17196465     DOI: 10.1016/j.amjcard.2006.07.068

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  31 in total

Review 1.  Cardiac resynchronization therapy in mild heart failure: a review of the REVERSE and MADIT-CRT trials.

Authors:  Carl R Reynolds; Michael R Gold
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

Review 2.  Optimal use of echocardiography in cardiac resynchronisation therapy.

Authors:  Gabe B Bleeker; Cheuk-Man Yu; Petros Nihoyannopoulos; Johan de Sutter; Nico Van de Veire; Eduard R Holman; Martin J Schalij; Ernst E van der Wall; Jeroen J Bax
Journal:  Heart       Date:  2007-11       Impact factor: 5.994

Review 3.  Physiology of biventricular pacing.

Authors:  Kenneth C Bilchick; Robert H Helm; David A Kass
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

4.  Imaging in cardiac resynchronisation therapy.

Authors:  C Ypenburg; E E van der Wall; M J Schalij; J J Bax
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

Review 5.  Imaging for planning of cardiac resynchronization therapy.

Authors:  Bobak Heydari; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  JACC Cardiovasc Imaging       Date:  2012-01

6.  Echocardiography in Takotsubo cardiomyopathy; a useful approach?

Authors:  E E van der Wall; E R Holman; A J Scholte; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-06       Impact factor: 2.357

7.  Cardiac resynchronization therapy; the importance of evaluating cardiac metabolism.

Authors:  E E van der Wall; M J Schalij; A van der Laarse; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-12       Impact factor: 2.357

Review 8.  Recent advances in cardiac resynchronization therapy: echocardiographic modalities, patient selection, optimization, non-responders--all you need to know for more efficient CRT.

Authors:  Harry Pavlopoulos; Petros Nihoyannopoulos
Journal:  Int J Cardiovasc Imaging       Date:  2009-11-25       Impact factor: 2.357

9.  Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy.

Authors:  Kenneth C Bilchick; Veronica Dimaano; Katherine C Wu; Robert H Helm; Robert G Weiss; Joao A Lima; Ronald D Berger; Gordon F Tomaselli; David A Bluemke; Henry R Halperin; Theodore Abraham; David A Kass; Albert C Lardo
Journal:  JACC Cardiovasc Imaging       Date:  2008-09

10.  Cardiac resynchronization therapy; evaluation by advanced imaging techniques.

Authors:  E E van der Wall; M J Schalij; J J Bax
Journal:  Int J Cardiovasc Imaging       Date:  2009-12-29       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.